Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coronary Thrombolysis.

John A. Cairns1

  • 1McMaster University Medical Centre, Hamilton, Ontario, Canada.

American Journal of Therapeutics
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Thrombolytic therapy for acute myocardial infarction shows benefits, but questions remain regarding optimal use, routine angiography, and primary angioplasty comparisons. Further research is needed for definitive answers on risk-benefit and cost-effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

American journal of therapeutics·2026
Same journal

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

American journal of therapeutics·2026
Same journal

Do Not Treat a Sequencing Report: Therapeutic Stewardship in Endometrial Microbiome Testing.

American journal of therapeutics·2026
Same journal

Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report.

American journal of therapeutics·2026
Same journal

Dose-Dependent Escitalopram-Induced Anejaculation and Anorgasmia: Rapid Reversal After Discontinuation and Bupropion Therapy.

American journal of therapeutics·2026
Same journal

Critical Appraisal of "Continued versus Interrupted Oral Anticoagulation During Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: A Meta-Analysis".

American journal of therapeutics·2026
See all related articles

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Thrombolytic therapy is a cornerstone treatment for acute myocardial infarction (AMI).
  • Existing randomized trials have established general benefits and risks of thrombolysis.
  • Several aspects of thrombolytic therapy and its alternatives require further investigation.

Purpose of the Study:

  • To address unresolved questions regarding thrombolytic therapy for AMI.
  • To evaluate the comparative efficacy and cost-effectiveness of different treatment strategies.
  • To discuss the role of routine angiography in patients receiving thrombolysis.

Main Methods:

  • Review and synthesis of data from randomized clinical trials.
  • Analysis of findings from the GUSTO trial comparing rt-PA and SK.

Related Experiment Videos

  • Discussion of current clinical guidelines and expert opinions.

    • Main Results:

    • The GUSTO trial demonstrated superior efficacy of rt-PA over SK for AMI.
    • The precise benefit size, risk-benefit ratios, and cost-effectiveness of rt-PA require further clarification.
    • The utility of routine coronary angiography post-thrombolysis remains debated due to limited evidence.

    Conclusions:

    • While rt-PA is more effective than SK, its exact benefits and cost-effectiveness need more study.
    • Routine angiography after thrombolysis is not currently recommended, but may be considered by some clinicians.
    • Primary angioplasty may offer benefits over thrombolysis, but further trials are needed to confirm outcomes and cost-effectiveness.